Zura Bio Ltd
Datakwaliteit: 83%
ZURA
Nasdaq
Manufacturing
Chemicals
€ 5,62
▼
€ 0,08
(-1,39%)
Marktkapitalisatie: 533,32 M
Prijs
€ 5,62
Marktkapitalisatie
533,32 M
Dagbereik
€ 5,55 — € 5,81
52-Weeksbereik
€ 0,98 — € 7,44
Volume
407.352
Openen € 5,67
50D / 200D Gem.
€ 6,26
10,15% below
50D / 200D Gem.
€ 3,82
47,19% above
Quick Summary
Belangrijkste Punten
Negative free cash flow of -64,93 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-58,64%
Onder sectorgemiddelde (-53,41%)
ROIC-46,16%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio5,58
Interest CoverageN/A
Waardering
PE (TTM)
-7,77
Onder sectorgemiddelde (-1,48)
P/B Ratio4,93
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -7,8 | -1,5 |
| P/B | 4,9 | 1,6 |
| ROE % | -58,6 | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -68,65 M |
| ROE | -58,64% | ROA | -45,50% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -64,93 M |
| ROIC | -46,16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 5,58 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 116,80 M | Tangible Book Value | 108,24 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -7,77 | Forward P/E | N/A |
| P/B Ratio | 4,93 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -12,17% | ||
| Market Cap | 533,32 M | Enterprise Value | 394,31 M |
| Per Share | |||
| EPS (Diluted TTM) | -1,06 | Revenue / Share | N/A |
| FCF / Share | -0,68 | OCF / Share | -0,68 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 94,58% |
| SBC-Adj. FCF | -83,33 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -68,65 M | -52,40 M | -60,36 M | 6,85 M | 3,55 M |
| EPS (Diluted) | -1,06 | -0,60 | -2,09 | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -75,25 M | -55,19 M | -62,64 M | -888.545,0 | -2,68 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 42,08 M | 24,40 M | 44,00 M | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 49.000,0 | 9.000,0 | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | — | 0,0 | 0,0 | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Total Assets | 113,95 M | 179,53 M | 100,84 M | 140,55 M | 141,51 M |
| Total Liabilities | 12,41 M | 19,51 M | 21,29 M | 10,35 M | 7,76 M |
| Shareholders' Equity | 101,54 M | 146,82 M | 59,33 M | -9,18 M | -7,63 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 109,41 M | 176,50 M | 99,80 M | 729.223,0 | 13.785,0 |
| Current Assets | 112,31 M | 178,74 M | 100,84 M | 1,15 M | 33.487,0 |
| Current Liabilities | 12,41 M | 19,51 M | 20,30 M | 272.292,0 | 1,83 M |
{"event":"ticker_viewed","properties":{"ticker":"ZURA","listing_kind":"stock","pathname":"/stocks/zura","exchange":"Nasdaq","country":"US"}}